← Back to Clinical Trials
Recruiting NCT06617663

NCT06617663 Online Therapy Youth, Equivalent to Treatment As Usual?

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06617663
Status Recruiting
Phase
Sponsor GGZ Noord-Holland-Noord
Condition Depression
Study Type INTERVENTIONAL
Enrollment 172 participants
Start Date 2024-07-01
Primary Completion 2026-06-01

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
EMDRACT

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 172 participants in total. It began in 2024-07-01 with a primary completion date of 2026-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

With growing waiting lists in specialized youth mental health care (sGGZ) and shortages of care staff, finding creative solutions to respond to this scarcity issue is important. Online treatment is an example of this, which, especially for young people growing up in a digital age, can be an appropriate and accessible alternative to treatment at a physical location. Online treatment via video calling among youth, while researched and proven effective in a blended form, has not yet been sufficiently researched as a complete replacement for treatment at a physical location. As a result, the potential added value of online treatment for the pressing scarcity issue in healthcare is not yet sufficiently clear. This study therefore focuses on investigating the effectiveness of fully online treatment using two proven effective interventions: Eye Movement Desensitization and Reprocessing (EMDR) and Acceptance and Commitment Therapy (ACT) within the youth sGGZ. With the results of this research at GGZ-NHN, the investigators want to contribute to the development of guidelines and standards for the implementation of online treatments within Dutch youth mental health care.

Eligibility Criteria

Inclusion Criteria: * Adolescents aged 12-18 years who would benefit from ACT or EMDR within the SGGZ, as determined by the screeners at registration or current primary practitioner. * Client is stable, i.e. there is no serious crisis (to be determined by screener cq primary practitioner) * Sufficient command of the Dutch language to complete the questionnaires. * Client does not participate in other (intervention) studies Exclusion Criteria: * Clients who are crisis-prone or enter in crisis * Clients who are in forced care (wvggz)

Contact & Investigator

Central Contact

Elles te Brake, Msc

✉ e.tebrake@ggz-nhn.nl

📞 0031623942414

Frequently Asked Questions

Who can join the NCT06617663 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06617663 currently recruiting?

Yes, NCT06617663 is actively recruiting participants. Contact the research team at e.tebrake@ggz-nhn.nl for enrollment information.

Where is the NCT06617663 trial being conducted?

This trial is being conducted at Alkmaar, Netherlands.

Who is sponsoring the NCT06617663 clinical trial?

NCT06617663 is sponsored by GGZ Noord-Holland-Noord. The trial plans to enroll 172 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology